Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Margaret, Nilsen"'
Autor:
Natasja Barki, Laura Jenkins, Sara Marsango, Domonkos Dedeo, Daniele Bolognini, Louis Dwomoh, Aisha M Abdelmalik, Margaret Nilsen, Manon Stoffels, Falko Nagel, Stefan Schulz, Andrew B Tobin, Graeme Milligan
Publikováno v:
eLife, Vol 12 (2023)
Free fatty acid receptor 2 (FFAR2) is activated by short-chain fatty acids and expressed widely, including in white adipocytes and various immune and enteroendocrine cells. Using both wild-type human FFAR2 and a designer receptor exclusively activate
Externí odkaz:
https://doaj.org/article/9b6b31128d5a4d21aaccb0f61f49509e
Autor:
Craig K. Docherty, Nina Denver, Simon Fisher, Margaret Nilsen, Dianne Hillyard, Rebecca L. Openshaw, Hicham Labazi, Margaret R. MacLean
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 22, Iss , Pp 396-405 (2020)
The 5HT1B receptor (5HT1BR) contributes to the pathogenic effects of serotonin in pulmonary arterial hypertension. Here, we determine the effect of a microRNA96 (miR96) mimic delivered directly to the lungs on development of severe pulmonary hyperten
Externí odkaz:
https://doaj.org/article/e5d263e8dc1b4639b7c47108893f55bc
Autor:
Geeshath Jayasekera, Kathryn S. Wilson, Hanna Buist, Rosemary Woodward, Aysel Uckan, Colin Hughes, Margaret Nilsen, A Colin Church, Martin K. Johnson, Lindsay Gallagher, James Mullin, Mandy R. MacLean, William M. Holmes, Andrew J. Peacock, David J. Welsh
Publikováno v:
Pulmonary Circulation, Vol 10 (2020)
Cardiac magnetic resonance-derived ventricular variables are predictive of mortality in pulmonary arterial hypertension. Rodent models which emphasize ventricular function, allowing serial monitoring, are needed to identify pathophysiological feature
Externí odkaz:
https://doaj.org/article/16df05497cb345c3b63ec397451bbf19
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 5 (2019)
Background Women are at greater risk of developing pulmonary arterial hypertension, with estrogen and its downstream metabolites playing a potential role in the pathogenesis of the disease. Hypoxia‐inducible factor‐1‐α (HIF1α) is a pro‐prol
Externí odkaz:
https://doaj.org/article/60705a9fce674838a45d67b5e1c30a50
Autor:
Hicham Labazi, Julie Birkmose Axelsen, Dianne Hillyard, Margaret Nilsen, Asger Andersen, Margaret R. MacLean
Publikováno v:
Biomedicines, Vol 8, Iss 10, p 430 (2020)
Right ventricular hypertrophy (RVH) and subsequent failure are consequences of pulmonary arterial hypertension (PAH). While females are four times more likely to develop PAH, male patients have poorer survival even with treatment, suggesting a sex-de
Externí odkaz:
https://doaj.org/article/6313fc8e6072443795423e6217b085e6
Autor:
Hanna Buist, Margaret Nilsen, Kathryn S. Wilson, Geeshath Jayasekera, A Colin Church, David J Welsh, Rosemary Woodward, Martin K Johnson, Lindsay Gallagher, Andrew J Peacock, Colin Hughes, Jim Mullin, William M. Holmes, Mandy MacLean, Aysel Uckan
Publikováno v:
Pulmonary Circulation
Pulmonary Circulation, Vol 10 (2020)
Pulmonary Circulation, Vol 10 (2020)
Cardiac magnetic resonance-derived ventricular variables are predictive of mortality in pulmonary arterial hypertension. Rodent models which emphasize ventricular function, allowing serial monitoring, are needed to identify pathophysiological feature
Publikováno v:
European Journal of Pharmacology
Methamphetamine (MA) abuse is associated with the development of pulmonary arterial hypertension (PAH) and subsequent right ventricular failure. A recent clinical study demonstrated that female sex is a major risk factor for MA-induced PAH. The mecha
Autor:
Margaret R. MacLean, Nina Denver, Rebecca L. Openshaw, Dianne Z. Hillyard, Craig K. Docherty, Margaret Nilsen, Hicham Labazi, Simon Fisher
Publikováno v:
Molecular Therapy. Nucleic Acids
Molecular Therapy: Nucleic Acids, Vol 22, Iss, Pp 396-405 (2020)
Molecular Therapy: Nucleic Acids, Vol 22, Iss, Pp 396-405 (2020)
The 5HT1B receptor (5HT1BR) contributes to the pathogenic effects of serotonin in pulmonary arterial hypertension. Here, we determine the effect of a microRNA96 (miR96) mimic delivered directly to the lungs on development of severe pulmonary hyperten
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b49af2e82db7d961eb98cef09cf0c51a
https://strathprints.strath.ac.uk/75323/1/Docherty_etal_MTNA_2020_Direct_delivery_of_microRNA96_to_the_lungs_reduces_progression.pdf
https://strathprints.strath.ac.uk/75323/1/Docherty_etal_MTNA_2020_Direct_delivery_of_microRNA96_to_the_lungs_reduces_progression.pdf
Autor:
Margaret Nilsen, Hicham Labazi, Julie Birkmose Axelsen, Dianne Z. Hillyard, Margaret R. MacLean, Asger Andersen
Publikováno v:
Biomedicines, Vol 8, Iss 430, p 430 (2020)
Biomedicines
Volume 8
Issue 10
Labazi, H, Axelsen, J B, Hillyard, D, Nilsen, M, Andersen, A & Maclean, M R 2020, ' Sex-dependent changes in right ventricular gene expression in response to pressure overload in a rat model of pulmonary trunk banding ', Biomedicines, vol. 8, no. 10, 430 . https://doi.org/10.3390/biomedicines8100430
Biomedicines
Volume 8
Issue 10
Labazi, H, Axelsen, J B, Hillyard, D, Nilsen, M, Andersen, A & Maclean, M R 2020, ' Sex-dependent changes in right ventricular gene expression in response to pressure overload in a rat model of pulmonary trunk banding ', Biomedicines, vol. 8, no. 10, 430 . https://doi.org/10.3390/biomedicines8100430
Right ventricular hypertrophy (RVH) and subsequent failure are consequences of pulmonary arterial hypertension (PAH). While females are four times more likely to develop PAH, male patients have poorer survival even with treatment, suggesting a sex-de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcfe0129e45c156fa96586e3a2575834
https://eprints.gla.ac.uk/228278/1/228278.pdf
https://eprints.gla.ac.uk/228278/1/228278.pdf
Autor:
Teja Gregorc, Craig K. Docherty, Afshan Dean, Margaret R. MacLean, Katie Y. Harvey, Margaret Nilsen, Nicholas W. Morrell
Publikováno v:
American Journal of Respiratory Cell and Molecular Biology. 58:320-330
Rationale: Rats dosed with the vascular endothelial growth factor (VEGF) inhibitor Sugen 5416 (Su), placed in hypoxia then restored to normoxia has become a widely used model of pulmonary arterial hypertension (PAH). The mechanism by which Su exaccer